MK-1925 (compound 39) is a ORL1 receptor antagonist with human IC50 values of 8.2 nM and 4.6 nM, as well as oral bioavailability and blood-brain barrier penetration. MK-1925 selectively inhibits the ORL1 receptor and shows no significant activity against other opioid receptors or the hERG potassium channel[1].
Molekulargewicht:
362.40
CAS Nummer:
[932705-04-9]
Formel:
C19H21F3N4
Target-Kategorie:
Opioid Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
